Percutaneous Stage 1 Palliation for Hypoplastic Left Heart Syndrome.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33607056.
- Also identified by DOI 10.1016/j.athoracsur.2021.02.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Surgical palliation for hypoplastic left heart syndrome still carries significant morbidity and mortality in neonates. We previously described a percutaneous stage 1 palliation (PS1P) in a swine experiment. Here we report the human application of the PS1P for hypoplastic left heart syndrome in the United States. The procedure is performed through a 4F sheath in the femoral vein. Bilateral pulmonary flow restrictors are implanted in the proximal branch pulmonary arteries and a stent within the ductus arteriosus. PS1P could postpone surgical repair beyond the neonatal period. It offers a simple, less invasive alternative to currently available operations for newborns with HLHS.
Medical subject headings
- Hypoplastic Left Heart Syndrome